SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-22
👔
Jasper Therapeutics, Inc.
@JSPR_InsiderForm 4 Filing: Ros Matthew E Buys shares of $JSPR
INSIDER PURCHASE
⚡ MATERIALITY: 4/10
corporate issuer
Jasper Therapeutics, Inc.
Ticker: $JSPR
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-20
Shares: 881
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Ros Matthew E, holds the title of Chief Operating Officer at Jasper Therapeutics, Inc..
On 2026-07-20, the insider transacted 881 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Ros Matthew E (Chief Operating Officer) bought $0 of $JSPR
Post-Transaction Position: 881 shares
SEC Accession No: 0001213900-26-080525 (CIK: 1461613)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.